Suppr超能文献

用于评估草药-药物相互作用的肝脏模型:方法与挑战

Hepatic Models to Assess Herb-Drug Interactions: Approaches and Challenges.

作者信息

N Hlengwa, C Masilela, T R Mtambo, S Sithole, S Naidoo, K E Machaba, S C Shabalala, Y Ntamo, P V Dludla, R N Milase

机构信息

Department of Biochemistry and Microbiology, University of Zululand, KwaDlangezwa 3886, South Africa.

Department of Biochemistry, North-West University, Mafikeng 2745, South Africa.

出版信息

Pharmaceuticals (Basel). 2023 Mar 8;16(3):409. doi: 10.3390/ph16030409.

Abstract

A newfound appreciation for the benefits of herbal treatments has emerged in recent decades. However, herbal medication production still needs to establish standardized protocols that adhere to strict guidelines for quality assurance and risk minimization. Although the therapeutic effects of herbal medicines are extensive, the risk of herb-drug interactions remains a serious concern, limiting their use. Therefore, a robust, well-established liver model that can fully represent the liver tissue is required to study potential herb-drug interactions to ensure herbal medicines' safe and effective use. In light of this, this mini review investigates the existing liver models applicable to detecting herbal medicines' toxicity and other pharmacological targets. This article analyzes the benefits and drawbacks of existing liver cell models. To maintain relevance and effectively express the offered research, a systematic strategy was employed to search for and include all discussed studies. In brief, from 1985 to December 2022, the phrases "liver models", "herb-drug interaction", "herbal medicine", "cytochrome P450", "drug transporters pharmacokinetics", and "pharmacodynamics" were combined to search the electronic databases PubMed, ScienceDirect, and the Cochrane Library.

摘要

近几十年来,人们对草药治疗的益处有了新的认识。然而,草药制剂的生产仍需建立标准化方案,以遵循严格的质量保证和风险最小化指南。尽管草药的治疗作用广泛,但草药与药物相互作用的风险仍然是一个严重问题,限制了它们的使用。因此,需要一个能够充分代表肝脏组织的强大、成熟的肝脏模型来研究潜在的草药与药物相互作用,以确保草药的安全有效使用。有鉴于此,本综述探讨了适用于检测草药毒性和其他药理学靶点的现有肝脏模型。本文分析了现有肝细胞模型的优缺点。为了保持相关性并有效表达所提供的研究内容,我们采用了一种系统策略来搜索并纳入所有讨论过的研究。简而言之,从1985年到2022年12月,我们将“肝脏模型”“草药与药物相互作用”“草药”“细胞色素P450”“药物转运体、药代动力学”和“药效学”等短语组合起来,搜索电子数据库PubMed、ScienceDirect和Cochrane图书馆。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fed/10058280/13104c2b254f/pharmaceuticals-16-00409-g001.jpg

相似文献

1
Hepatic Models to Assess Herb-Drug Interactions: Approaches and Challenges.
Pharmaceuticals (Basel). 2023 Mar 8;16(3):409. doi: 10.3390/ph16030409.
2
A Systematic Review of Drug Metabolism Studies of Plants With Anticancer Properties: Approaches Applied and Limitations.
Eur J Drug Metab Pharmacokinet. 2020 Apr;45(2):173-225. doi: 10.1007/s13318-019-00582-8.
3
Evaluation of metabolism-mediated herb-drug interactions.
Arch Pharm Res. 2011 Nov;34(11):1829-42. doi: 10.1007/s12272-011-1105-0. Epub 2011 Dec 3.
4
Herb-Drug Interactions and Hepatotoxicity.
Curr Drug Metab. 2019;20(4):275-282. doi: 10.2174/1389200220666190325141422.
5
Pharmacovigilance of herbal medicines: Concerns and future prospects.
J Ethnopharmacol. 2023 Jun 12;309:116383. doi: 10.1016/j.jep.2023.116383. Epub 2023 Mar 12.
6
Pharmacokinetic Herb-Drug Interactions: Insight into Mechanisms and Consequences.
Eur J Drug Metab Pharmacokinet. 2016 Apr;41(2):93-108. doi: 10.1007/s13318-015-0296-z.
7
Potential of pharmacokinetic profiling for detecting herbal interactions with drugs.
Clin Pharmacokinet. 2008;47(6):383-97. doi: 10.2165/00003088-200847060-00003.
8
Evaluation of potential herb-drug interactions between oseltamivir and commonly used anti-influenza Chinese medicinal herbs.
J Ethnopharmacol. 2019 Oct 28;243:112097. doi: 10.1016/j.jep.2019.112097. Epub 2019 Jul 17.

本文引用的文献

1
Liver organ-on-chip models for toxicity studies and risk assessment.
Lab Chip. 2022 Jun 28;22(13):2423-2450. doi: 10.1039/d2lc00307d.
2
Best Practices and Progress in Precision-Cut Liver Slice Cultures.
Int J Mol Sci. 2021 Jul 1;22(13):7137. doi: 10.3390/ijms22137137.
3
COVID-19 Pandemic: A Case for Phytomedicines.
Nat Prod Commun. 2020 Aug 14;15(8):1934578X20945086. doi: 10.1177/1934578X20945086. eCollection 2020 Aug.
5
Experimental liver models: From cell culture techniques to microfluidic organs-on-chip.
Liver Int. 2021 Aug;41(8):1744-1761. doi: 10.1111/liv.14942. Epub 2021 May 26.
6
Advancements in stem cell-derived hepatocyte-like cell models for hepatotoxicity testing.
Stem Cell Res Ther. 2021 Jan 25;12(1):84. doi: 10.1186/s13287-021-02152-9.
7
Hepatocellular carcinoma (HepG2/C3A) cell-based 3D model for genotoxicity testing of chemicals.
Sci Total Environ. 2021 Feb 10;755(Pt 2):143255. doi: 10.1016/j.scitotenv.2020.143255. Epub 2020 Nov 3.
8
HepG2 (C3A) spheroids show higher sensitivity compared to HepaRG spheroids for drug-induced liver injury (DILI).
Toxicol Appl Pharmacol. 2020 Dec 1;408:115279. doi: 10.1016/j.taap.2020.115279. Epub 2020 Oct 14.
9
Microfluidic organ-on-a-chip models of human liver tissue.
Acta Biomater. 2020 Oct 15;116:67-83. doi: 10.1016/j.actbio.2020.08.041. Epub 2020 Sep 2.
10
Precision-cut liver slices as an alternative method for long-term hepatotoxicity studies.
Arch Toxicol. 2020 Aug;94(8):2889-2891. doi: 10.1007/s00204-020-02861-9. Epub 2020 Jul 18.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验